Nuclear matrix protein fluid assay
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 25, 2002
Issued Date -
N/A
app pub date -
Oct 12, 2000
filing date -
Oct 31, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed is a method for detecting and quantitating soluble nuclear matrix proteins in body fluids and extracellular media. The method is useful for monitoring the viability of cells and tissue, for evaluating the progress of a disease or its treatment, and for evaluating the cytotoxicity of unknown compounds. Also disclosed are methods for inducing the release of nuclear matrix proteins in soluble form from cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully